With advancing age, circulating growth hormone and plasma IGF-I levels decline in both humans and animal models, further supporting the involvement of IGF-I in sarcopenia (Sonntag et al., 1980; Florini et al., 1981; Ferrari et al., 2021). Here, GH1 is linked to sarcopenia.